A
New York Times article revealed that Horizon Pharma (Nasdaq: HZNP)
charges $1,500 per month for Duexis which should cost approximately $60 per
month. Shares of the biopharmaceutical plunged $3.81 to close at $15.26.
NY Times says Horizon Pharma overcharges
October 20, 2015 at 18:35 PM EDT
